Get the Daily Brief
Latest Biotech News
Breakthrough glioblastoma therapy targets nonmuscle myosin to enhance treatment sensitivity
Researchers have developed MT-125, a nonmuscle myosin II inhibitor that penetrates the brain, effectively reduces glioblastoma invasiveness, and sensitizes resistant tumors to kinase inhibitors...
New machine learning models improve cancer prognosis and diagnostics
Researchers have unveiled advanced AI and machine learning models that enhance early diagnosis and prognosis prediction across various cancers. Notably, radiomics-based CT models differentiate...
Innovations in biomanufacturing accelerate gene and cell therapy production
Bioprocessing platforms are evolving toward modular, flexible, and automated systems to efficiently produce diverse gene-edited therapies at scale. Ori Biotech exemplifies this shift with...
Advances in sustainable materials and environmental biotech for health and agriculture
Recent breakthroughs in sustainable science include development of biodegradable cellulose foams mimicking bread baking, novel 3D-printable bioinks from drought-tolerant sorghum proteins, and gut...
Immunotherapy Advances in Liver Cancer: Dual vs Monotherapy Approaches
Recent clinical studies have highlighted significant progress in immunotherapy for hepatocellular carcinoma (HCC). One multicentric investigation across India confirmed the safety and efficacy of...
Innovations in Glioblastoma Treatment: Targeted Drugs and Microbiome Influence
Glioblastoma remains a formidable brain tumor with limited effective treatments. Researchers have identified new therapeutic candidates such as MT-125, a compound that inhibits non-muscle myosin...
AI and Machine Learning Empower Cancer Diagnosis and Prognosis
Artificial intelligence (AI) is increasingly integrated into oncology for improving early detection and disease management. A new machine learning model developed at the University of Sharjah...
Advancements in 3D Printing and Bioink Materials for Food and Pharmaceuticals
Recent breakthroughs exploit novel material bases for 3D printing applications in food and medicine. Sorghum proteins, known for their drought resistance and hydrophobic properties, have been...
Epigenetics and Molecular Biomarkers in Cancer and Disease
Researchers have identified key molecular markers and mechanisms driving cancer and other diseases. A landmark study detailed the epigenetic diversity in advanced prostate cancer, revealing...
Regulatory and Industry Dynamics Amid HHS Reorganization and Biotech Funding
The U.S. Department of Health and Human Services (HHS) faces legal injunctions halting planned workforce reductions, stemming from lawsuits alleging unauthorized agency restructuring....
Psychedelic Therapies Advance with Positive Clinical Data and Strategic Mergers
Clinical advancements in psychedelic-based treatments are accelerating notably. Beckley Psytech’s intranasal mebufotenin demonstrated significant symptom reductions in treatment-resistant...
Breakthroughs in Oncology: Bispecific Antibodies and Tumor Immunology
Regeneron Pharmaceuticals achieved FDA accelerated approval for Lynozyfic (linvoseltamab), a bispecific antibody targeting BCMA and CD3 in multiple myeloma, marking a significant milestone in...
AI Integration and Innovation in Biomanufacturing and Diagnostic Tools
The incorporation of artificial intelligence (AI) across biomanufacturing and diagnostics is gaining strategic momentum. While regulators like the FDA and EMA explore adaptive frameworks to...
Genomic and Molecular Technology Development for Precision Medicine
Cutting-edge tools in genomics and molecular biology continue to enable transformative advances in medicine. Novel methods for accurate CRISPR off-target prediction have improved with...
FDA Halts HHS Layoffs: Court Challenges Agency Restructuring
Two federal courts have issued preliminary injunctions blocking parts of the U.S. Department of Health and Human Services’ (HHS) broad reorganization plans and workforce reductions, siding with...
Regeneron Gains US Approval for Multiple Myeloma Bispecific Antibody
Regeneron has secured accelerated FDA approval for linvoseltamab, its bispecific antibody targeting multiple myeloma in adults with relapsed or refractory disease. This milestone follows delays...
Advances in AI-Driven Diagnostic and Drug Discovery Platforms
Several biotech firms and academic centers are leveraging artificial intelligence to accelerate diagnostics and therapeutic development. Adaptive Biotechnologies has integrated its ClonoSeq MRD...
Biotech Venture Funds Capitalize on Market Opportunities
Venture capital firms continue to capitalize on attractive valuations in biotechnology. Catalio Capital Management closed its fourth fund at over $400 million, deploying capital into innovative...
Psychedelic Therapies Show Promise in Treatment-Resistant Depression
Beckley Psytech and Atai Life Sciences announced positive Phase 2b data for intranasal mebufotenin (BPL-003), demonstrating significant symptom reductions in treatment-resistant depression versus...
Chemotherapy’s Genetic Impact Provides Insight for Safer Cancer Treatments
A comprehensive genomic study has identified distinct mutational signatures in normal blood cells correlated with exposure to 21 different chemotherapy drugs. Led by the Wellcome Sanger Institute...